Drug therapy for asymp -tomatic carriers of SARS-CoV-2
- Autores: Burashnikova I.S1, Tsvetov V.M2
-
Afiliações:
- Kazan State Medical Academy - branch of the Russian Medical Academy of Continuous Professional Education
- Federal Center for Cardiovascular Surgery
- Edição: Volume 27, Nº 13 (2020)
- Páginas: 14-16
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312959
- DOI: https://doi.org/10.18565/pharmateca.2020.13.14-16
- ID: 312959
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
The possibility of using antiseptics and enzyme preparations for topical use in asymptomatic carriers of SARS-CoV-2 is being studied. In an uncontrolled study in a limited number of patients (n=7), an inhibitory effect of H2O2 on viral shedding for at least 48 hours was shown. Drug therapy in asymptomatic carriers of SARS-CoV-2 currently does not have sufficient scientific justification for routine use in clinical practice.
Palavras-chave
Texto integral
Sobre autores
I. Burashnikova
Kazan State Medical Academy - branch of the Russian Medical Academy of Continuous Professional Education
V. Tsvetov
Federal Center for Cardiovascular Surgery
Bibliografia
- https://www.covid19treatmentguidelines.nih. gov/overview/clinical-presentation/ (accessed: 12.10.2020).
- Prevalence and Symptom Development Over Two Weeks. Am J Obstet Gynecol MFM. 2020 Sep 11:100226. Doi: 10.1016/j. ajogmf.2020.100226.
- Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). 9-е изд. М., 2020. [Temporary guidelines. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). 9th ed. M., 2020. (In Russ.)].
- Rothe C., Schunk M., Sothmann P., et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970-71.
- Yu., Zhu J., Zhang Z., Han Y, Huang L. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J Infect Dis. 2020;221(11): 1757-61.
- Bai Y, Yao L., Wei T., et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406-407. Available at: https://www.ncbi.nlm.nih.gov/ pubmed/32083643. (accessed: 12.10.2020).
- Coronavirus Disease 2019 (COVID-19) Treatment Guidelines NIH [Electronic resource]. URL: https://files.covid19treatmentguidelines. nih.gov/guidelines/covid19treatmentguidelines. pdf (accessed: 12.10.2020).
- National COVID-19 Clinical Evidence Taskforce [Electronic resource]. URL: https:// covid19evidence.net.au/ (accessed: 12.10.2020).
- UW Medicine COVID-19 Resource Site [Electronic resource]. University of Washington. 2020. URL: https://covid-19.uwmedicine.org/ Pages/default.aspx (accessed: 12.10.2020).
- https://www.cdc.gov/coronavirus/2019-ncov/ hcp/clinical-guidance-management-patients. html (accessed: 12.10.2020).
- Brigham and Women's Hospital COVID-19 Clinical Guidelines [Electronic resource]. URL: https://covidprotocols.org/ (accessed: 12.10.2020).
- https://covidprotocols.herokuapp.com/pdf/ Covid-19%20Outpatient%20Guide%20 092020.1.pdf (accessed: 12.10.2020).
- http://grls.rosminzdrav.ru/CiPermitionReg. aspx?PermYear=0&DateInc=&NumInc=&Da teBeg=&DateEnd=&Protocol=sars&RegNm= &Statement=&ProtoNum=&idCIStatementC h=&Qualifier=&CiPhase=&RangeOfApp=& Torg=&LFDos=&Producer=&Recearcher=&s ponsorCountry=&MedBaseCount=&CiType= &PatientCount=&OrgDocOut=2&Status=& NotInReg=0&All=0&PageSize=8&order=da te_perm&orderType=desc&pagenum=1 (дата обращения/access: 12.10.2020)
- http://www.anzctr.org.au/TrialSearch.aspx#& &conditionCode=&dateOfRegistrationFrom=& interventionDescription=&interventionCodeO perator=OR&primarySponsorType=&gender= &distance=&postcode=&pageSize=20&ageG roup=&recruitmentCountryOperator=OR&rec ruitmentRegion=ðicsReview=&countryOfR ecruitment=Australia%7cNew+Zealand®is try=ANZCTR&searchTxt=bromac&studyType= &allocationToIntervention=&dateOfRegistrati onTo=&recruitmentStatus=&interventionCode =Prevention%7cTreatment%3a+Drugs&healt hCondition=covid&healthyVolunteers=&page = 1&conditionCategory=&fundingSource=&tr ialStartDateTo=&trialStartDateFrom=&phase= (accessed: 12.10.2020).
- Shortterm inhibition of SARSCoV2 by hydrogen peroxide in persistent nasopharyngeal carriers Amedeo F. Capetti Fabio Borgonovo Valentina Morena Angelica Lupo Maria Vittoria Cossu Matteo Passerini Gianfranco Dedivitiis Giuliano Rizzardini First published: 03 September 2020. https://doi.org/10.1002/jmv.264853. (accessed: 12.10.2020).
Arquivos suplementares
